The molecular and genetic basis of inherited cancer risk in gynaecology-Reference-Cited by-同舟云学术

The molecular and genetic basis of inherited cancer risk in gynaecology

Published:2015-10 Issue:4 Volume:17 Page:233-241
ISSN:1467-2561
Container-title:The Obstetrician & Gynaecologist
language:en
Short-container-title:Obstet Gynecol

Author:

Beirne James P¹,Irwin Gareth W²,McIntosh Stuart A²,Harley Ian JG¹,Harkin D Paul³

Affiliation:

1. Northern Ireland Gynaecological Cancer Centre; Belfast City Hospital; Belfast Health and Social Care Trust; Belfast, Northern Ireland and Gynaecological Cancer Research Focus Group; Centre for Cancer Research and Cell Biology; Queens University; Belfast Northern Ireland

2. Northern Ireland Regional Breast Unit, Belfast City Hospital; Belfast Health and Social Care Trust; Belfast; Northern Ireland and Breast Cancer Research Focus Group; Centre for Cancer Research and Cell Biology; Queens University; Belfast Northern Ireland

3. Breast Cancer Research Focus Group; Centre for Cancer Research and Cell Biology; Queens University; Belfast Northern Ireland

Publisher

Wiley

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tog.12213/fullpdf

Reference84 articles.

1. The hallmarks of cancer;Hanahan;Cell,2000

2. Genomic instability-an evolving hallmark of cancer;Negrini;Nat Rev Mol Cell Biol,2010

3. Highly penetrant hereditary cancer syndromes;Nagy;Oncogene,2004

4. PARP inhibition: targeting the Achilles’ heel of DNA repair to treat germline and sporadic ovarian cancers;Carden;Curr Opin Oncol,2010

5. Molecular pathogenesis of Fanconi anemia: recent progress;Taniguchi;Blood,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A bespoke target selection tool to guide biomarker discovery in tubo-ovarian cancer;Computational and Structural Biotechnology Journal;2022

2. References;Constitutional Oncogenetics;2021-04-20

3. Liquid biopsy in ovarian cancer: Catching the silent killer before it strikes;World Journal of Clinical Oncology;2020-11-24

4. Defining the molecular evolution of extrauterine high grade serous carcinoma;Gynecologic Oncology;2019-11

5. Molecular therapy using siRNA: Recent trends and advances of multi target inhibition of cancer growth;International Journal of Biological Macromolecules;2018-09